Closing ALTH (Allos Therapeutics) outperform
I think the party may be over for Allos, at least for a while. They've had a nice run since I picked them just before they released interim data for PROPEL, and I think they're now overpriced given the high degree of risk. They may have another upward movement with interim safety data released from PROPEL by the end of 2007, after which I'll probably short them if the price hasn't already trailed down substantially. Another reason I'm selling is that I simply have too many active picks to follow closely, and I need to close some of my lower yielders.